• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000-2009 年台湾某医学中心培养阳性的侵袭性曲霉菌病。

Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.

机构信息

School of Medicine, National Taiwan University College of Medicine, Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1319-26. doi: 10.1007/s10096-011-1445-1. Epub 2011 Oct 14.

DOI:10.1007/s10096-011-1445-1
PMID:21997774
Abstract

We reviewed 776 patients who were culture positive for Aspergillus species at the hospital from 2000 to 2009. The isolates were collected for species identification by oligonucleotide hybridization and sequence analysis. A total of 96 cases of proven or probable IA were identified according to published criteria. The incidence of IA has increased significantly during the study period. Aspergillus fumigatus and A. flavus (41.7% each) were equally prevalent causative species. IA due to unusual species including A. nidulans (n=2), A. versicolor (n=2), and A. tubingensis (n=1) were also found. Among patients with IA, 55.2% had hematological disorder, 19.8% had underlying lung disorder, and 10.4% had autoimmune disease. The isolates species (P<0.001) and underlying disease (P<0.001) significantly affect the association of a positive culture with invasive disease. The overall mortality at three months was 62.5%, which remained stable throughout the study period. Multivariate analysis identified prior steroid use (P=0.007) as a significant risk factor for death, while surgery (P=0.030) and voriconazole (P=0.012) had protective effects. In conclusion, autoimmune disorders and underlying pulmonary diseases should also be considered as important predisposing factors of IA. Further emphasis on surgery and voriconazole in the management of IA might be beneficial.

摘要

我们回顾了 2000 年至 2009 年期间在医院培养出的 776 株曲霉菌属物种的阳性患者。通过寡核苷酸杂交和序列分析对分离株进行了种属鉴定。根据发表的标准,共确定了 96 例确诊或疑似侵袭性曲霉病病例。在研究期间,IA 的发病率显著增加。烟曲霉和黄曲霉(各占 41.7%)是同样常见的致病物种。由于包括棘孢曲霉(n=2)、杂色曲霉(n=2)和构巢曲霉(n=1)在内的不常见物种引起的 IA 也有发现。在 IA 患者中,55.2%有血液系统疾病,19.8%有肺部基础疾病,10.4%有自身免疫性疾病。分离株的种属(P<0.001)和基础疾病(P<0.001)显著影响阳性培养与侵袭性疾病的关联。三个月时的总体死亡率为 62.5%,在整个研究期间保持稳定。多变量分析确定了先前使用类固醇(P=0.007)是死亡的显著危险因素,而手术(P=0.030)和伏立康唑(P=0.012)具有保护作用。总之,自身免疫性疾病和肺部基础疾病也应被视为 IA 的重要易感因素。在 IA 的治疗中进一步强调手术和伏立康唑可能是有益的。

相似文献

1
Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.2000-2009 年台湾某医学中心培养阳性的侵袭性曲霉菌病。
Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1319-26. doi: 10.1007/s10096-011-1445-1. Epub 2011 Oct 14.
2
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).法国侵袭性曲霉菌病的流行病学趋势:SAIF 网络(2005-2007 年)。
Clin Microbiol Infect. 2011 Dec;17(12):1882-9. doi: 10.1111/j.1469-0691.2011.03548.x. Epub 2011 Jun 10.
3
A retrospective study of the epidemiology and clinical manifestation of invasive aspergillosis in a major tertiary care hospital in Bahrain.巴林一家大型三级护理医院侵袭性曲霉病的流行病学和临床表现回顾性研究。
J Infect Public Health. 2017 Jan-Feb;10(1):49-58. doi: 10.1016/j.jiph.2016.02.015. Epub 2016 Mar 29.
4
Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.伏立康唑耐药与侵袭性曲霉病患者死亡率的相关性:一项多中心回顾性队列研究。
Clin Infect Dis. 2019 Apr 24;68(9):1463-1471. doi: 10.1093/cid/ciy859.
5
Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.实体瘤患者侵袭性肺曲霉病:危险因素和临床结局的预测因素。
Ann Med. 2018 Dec;50(8):713-720. doi: 10.1080/07853890.2018.1518581. Epub 2018 Sep 29.
6
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.急性白血病患者侵袭性曲霉菌病和唑类耐药的流行病学:SEPIA 研究。
Int J Antimicrob Agents. 2017 Feb;49(2):218-223. doi: 10.1016/j.ijantimicag.2016.10.019. Epub 2016 Dec 12.
7
Invasive aspergillosis in developing countries.发展中国家的侵袭性曲霉病。
Med Mycol. 2011 Apr;49 Suppl 1:S35-47. doi: 10.3109/13693786.2010.505206. Epub 2010 Aug 18.
8
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.重症监护病房空气中的孢子导致大型心脏手术后侵袭性曲霉菌病的爆发。
Clin Infect Dis. 2012 Feb 1;54(3):e24-31. doi: 10.1093/cid/cir771.
9
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.1999-2015 年,三级癌症中心曲霉菌对唑类药物的体外敏感性模式变化及其与曲霉病结局的相关性。
Clin Infect Dis. 2017 Jul 15;65(2):216-225. doi: 10.1093/cid/cix297.
10
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.非中性粒细胞减少患者的侵袭性肺曲霉病:一项为期14个月的前瞻性临床经验分析。
J Chemother. 2011 Oct;23(5):290-4. doi: 10.1179/joc.2011.23.5.290.

引用本文的文献

1
Clinical applications of immunoglobulin G against different individual species for the diagnosis of chronic pulmonary aspergillosis among at-risk populations.针对不同个体物种的免疫球蛋白G在高危人群慢性肺曲霉病诊断中的临床应用。
Pathog Glob Health. 2024 Oct-Dec;118(7-8):574-581. doi: 10.1080/20477724.2024.2424489. Epub 2024 Nov 6.
2
Comparison of -specific antibody cut-offs for the diagnosis of aspergillosis.用于诊断曲霉病的特异性抗体临界值比较。
Front Microbiol. 2022 Dec 6;13:1060727. doi: 10.3389/fmicb.2022.1060727. eCollection 2022.
3
Differential Kinetics of Aspergillus nidulans and Aspergillus fumigatus Phagocytosis.

本文引用的文献

1
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.实体器官移植受者侵袭性真菌感染的流行病学及结局
Transpl Infect Dis. 2010 Jun;12(3):220-9. doi: 10.1111/j.1399-3062.2010.00492.x. Epub 2010 Jan 25.
2
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.慢性阻塞性肺疾病患者的肺部曲霉菌病:发病率、危险因素和结局。
Clin Microbiol Infect. 2010 Jul;16(7):870-7. doi: 10.1111/j.1469-0691.2009.03015.x. Epub 2009 Nov 10.
3
Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
青霉和烟曲霉吞噬作用的差异动力学。
J Innate Immun. 2018;10(2):145-160. doi: 10.1159/000484562. Epub 2017 Dec 16.
4
Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan.侵袭性肺曲霉病的临床结局及相关预后因素:来自台湾的11年随访报告
PLoS One. 2017 Oct 19;12(10):e0186422. doi: 10.1371/journal.pone.0186422. eCollection 2017.
5
Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan.半乳甘露聚糖检测与侵袭性肺曲霉病发病率:台湾一项基于全国人群的10年研究
PLoS One. 2016 Feb 22;11(2):e0149964. doi: 10.1371/journal.pone.0149964. eCollection 2016.
6
Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins.中国黑曲霉群的鉴定与易感性:菌种流行情况及对棘白菌素的矛盾生长反应
J Clin Microbiol. 2015 Feb;53(2):702-5. doi: 10.1128/JCM.03233-14. Epub 2014 Dec 10.
过去十年间儿科血液肿瘤患者侵袭性曲霉病发病率上升:一项回顾性单中心研究
J Pediatr Hematol Oncol. 2009 Sep;31(9):642-6. doi: 10.1097/MPH.0b013e3181acd956.
4
Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.用于移植相关感染监测网络的曲霉属种的分子鉴定。
J Clin Microbiol. 2009 Oct;47(10):3138-41. doi: 10.1128/JCM.01070-09. Epub 2009 Aug 12.
5
Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea.韩国天主教大学附属医院系统性红斑狼疮患者侵袭性真菌感染的经验
Lupus. 2009 Jun;18(7):661-6. doi: 10.1177/0961203309103081.
6
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.黄曲霉:一种具有重要意义的新兴非烟曲霉菌种。
Mycoses. 2009 May;52(3):206-22. doi: 10.1111/j.1439-0507.2008.01642.x. Epub 2009 Jan 14.
7
Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients.半乳甘露聚糖可作为中性粒细胞减少血液学患者侵袭性肺曲霉病预后的替代终点。
Cancer. 2009 Jan 15;115(2):355-62. doi: 10.1002/cncr.24022.
8
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.成年造血干细胞移植受者侵袭性真菌感染的流行病学及转归:多中心前瞻性抗真菌治疗(PATH)联盟登记研究分析
Clin Infect Dis. 2009 Feb 1;48(3):265-73. doi: 10.1086/595846.
9
Factors associated with overall and attributable mortality in invasive aspergillosis.侵袭性曲霉病中与总死亡率和归因死亡率相关的因素。
Clin Infect Dis. 2008 Nov 1;47(9):1176-84. doi: 10.1086/592255.
10
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.欧洲癌症研究与治疗组织/侵袭性真菌感染合作组和美国国立过敏与传染病研究所真菌病研究组(EORTC/MSG)共识组对侵袭性真菌病的修订定义。
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.